BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19844206)

  • 1. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
    Dong C; Wong ML; Licinio J
    Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
    Licinio J; Dong C; Wong ML
    Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.
    Licinio J; O'Kirwan F; Irizarry K; Merriman B; Thakur S; Jepson R; Lake S; Tantisira KG; Weiss ST; Wong ML
    Mol Psychiatry; 2004 Dec; 9(12):1075-82. PubMed ID: 15365580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
    Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
    Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.
    Yin L; Zhang YY; Zhang X; Yu T; He G; Sun XL
    Pharmacopsychiatry; 2015 May; 48(3):95-103. PubMed ID: 25642918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder.
    Ng CH; Bousman C; Smith DJ; Dowling N; Byron K; King J; Sarris J
    Pharmacopsychiatry; 2016 Sep; 49(5):210-212. PubMed ID: 27023264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.
    Xu Z; Zhang Z; Shi Y; Pu M; Yuan Y; Zhang X; Li L
    J Affect Disord; 2011 Sep; 133(1-2):165-73. PubMed ID: 21680027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine and serotonin transporter genes: impact on treatment response in depression.
    Baffa A; Hohoff C; Baune BT; Müller-Tidow C; Tidow N; Freitag C; Zwanzger P; Deckert J; Arolt V; Domschke K
    Neuropsychobiology; 2010; 62(2):121-31. PubMed ID: 20588071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the Han Chinese population.
    Yang B; Huang X; Ruan L; Yu T; Li X; Jesse FF; Cao Y; Li X; Liu B; Yang F; Lee YS; He L; Li W; He G
    Neurosci Lett; 2014 Sep; 579():114-8. PubMed ID: 25019689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
    Murphy GM; Sarginson JE; Ryan HS; O'Hara R; Schatzberg AF; Lazzeroni LC
    Pharmacogenet Genomics; 2013 Jun; 23(6):301-13. PubMed ID: 23619509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
    Singh AB; Bousman CA; Ng CH; Byron K; Berk M
    Transl Psychiatry; 2012 Nov; 2(11):e198. PubMed ID: 23188198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of the serotonin transporter and associations with antidepressant response.
    Kraft JB; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2005 Sep; 58(5):374-81. PubMed ID: 15993855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study.
    Deflesselle E; Colle R; Rigal L; David DJ; Vievard A; Martin S; Becquemont L; Verstuyft C; Corruble E
    PLoS One; 2018; 13(10):e0205648. PubMed ID: 30308049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
    Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
    Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
    Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC6A4 variation and citalopram response.
    Mrazek DA; Rush AJ; Biernacka JM; O'Kane DJ; Cunningham JM; Wieben ED; Schaid DJ; Drews MS; Courson VL; Snyder KA; Black JL; Weinshilboum RM
    Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):341-51. PubMed ID: 18618621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
    Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
    Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.